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Escherichia coli K1 is a major gram-negative organism causing neonatal meningitis. E. coli K1 binding to and
invasion of human brain microvascular endothelial cells (HBMEC) are a prerequisite for E. coli penetration
into the central nervous system in vivo. In the present study, we showed using DNA microarray analysis that
E. coli K1 associated with HBMEC expressed significantly higher levels of the fim genes compared to nonas-
sociated bacteria. We also showed that E. coli K1 binding to and invasion of HBMEC were significantly
decreased with its fimH deletion mutant and type 1 fimbria locked-off mutant, while they were significantly
increased with its type 1 fimbria locked-on mutant. E. coli K1 strains associated with HBMEC were predom-
inantly type 1 fimbria phase-on (i.e., fimbriated) bacteria. Taken together, we showed for the first time that type
1 fimbriae play an important role in E. coli K1 binding to and invasion of HBMEC and that type 1 fimbria
phase-on E. coli is the major population interacting with HBMEC.
The mortality and morbidity associated with neonatal gram-
negative bacterial meningitis have remained significant despite
advances in antimicrobial chemotherapy. This is mainly attrib-
uted to inadequate knowledge of the pathogenesis and patho-
physiology of this disease. Escherichia coli K1 is the most com-
mon gram-negative bacterium that causes meningitis during
the neonatal period (26).
E. coli meningitis develops as a result of hematogenous
spread, but it is not clear how circulating bacteria cross the
blood-brain barrier. Our laboratory has successfully isolated
and cultivated human brain microvascular endothelial cells
(HBMEC), which constitute the blood-brain barrier (9, 10).
We showed that E. coli invasion of HBMEC is a prerequisite
for E. coli penetration into the central nervous system in vivo.
However, the basis of E. coli-HBMEC interactions involved in
binding to HBMEC is incompletely understood.
Adherence of bacteria to their host cells is considered the
initial step of the pathogenesis of infectious diseases including
meningitis. To date OmpA is the only identified determinant
that is involved in E. coli K 1 binding to HBMEC (8, 10).
Previous reports have implied that S fimbriae might be another
potential E. coli K1 factor involved in adherence to HBMEC
(3, 16, 24, 32). However, according to our recent data, S fim-
briae do not play a significant role in binding of E. coli K1 to
HBMEC (35).
Type 1 fimbriae are filamentous surface organelles produced
by E. coli and mediate mannose-sensitive adhesion of E. coli to
various eukaryotic cells. In E. coli K1, type 1 fimbriae have
been shown to be important for oropharyngeal colonization in
a neonatal rat model (4). Type 1 fimbriae are encoded by a fim
gene cluster, including at least nine genes required for their
biosynthesis (20). The fimbriae are composed primarily of the
major FimA protein and a small tip structure containing FimF,
FimG, and FimH (12). The lectin-like adhesin, FimH, located
at the tip of the fimbrial shaft is responsible for the mannose-
sensitive adhesion to eukaryotic host cells (7).
Expression of type 1 fimbria is regulated by a phase variation
in which each individual bacterium can alternate between fim-
briated and nonfimbriated states, also called “phase on” and
“phase off,” respectively (1). The phase switching is deter-
mined by the orientation of a 314-bp chromosomal region that
contains the promoter of fim structure genes and is located
upstream of fimA. The 314-bp invertible element is flanked
with 9-bp invert repeats, the left invert repeat (IRL) and the
right invert repeat. By recognizing the flanking invert se-
quences this inversion is catalyzed by two site-specific recom-
binases, FimB and FimE, encoded upstream of the invertible
element (13).
The present study was carried out to examine the role of
type 1 fimbriae in the pathogenesis of E. coli meningitis, i.e., E.
coli K1 binding to and invasion of HBMEC. We constructed a
fimH deletion mutant and type 1 fimbria phase-locked mutants
of E. coli K1 and compared their binding and invasion capa-
bilities in HBMEC compared to the parent E. coli K1 strain.
We also examined the populations of E. coli K1 associated with
HBMEC by invertible element orientation assay and DNA
microarray.
MATERIALS AND METHODS
Endothelial cell culture and bacterial strain and culture condition. HBMEC
were isolated and cultured as previously described (31). HBMEC cultures were
grown in RPMI 1640 containing 10% heat-inactivated fetal bovine serum, 10%
Nu-Serum, 2 mM glutamine, 1 mM pyruvate, penicillin (100 U/ml), streptomycin
(100 g/ml), essential amino acids, and vitamins. E. coli K1 strain RS218 (O18:
K1:H7) is a cerebrospinal fluid isolate from a neonate with meningitis. E. coli
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strains were grown at 37°C overnight in brain heart infusion (BHI) broth with
shaking at 200 rpm.
Antibodies and antisera. Anti-FimH antiserum was derived by using FimH
recombinant protein as follows. The N-terminal fimH of E. coli K1 RS218, which
encodes the amino acid residues 1 to 156, was cloned into the expression vector
pBAD/Thio-TOPO (Invitrogen, Carlsbad, CA) and the C-terminal part of the
DNA fragment was fused to a six-His tag from the plasmid. The recombinant
FimH proteins were expressed and purified by nickel-charged Sepharose resins
per the manufacturer’s instructions. Anti-FimH antiserum was obtained by im-
munizing New Zealand White rabbits with the purified recombinant protein as
described previously (33).
Anti-type 1 fimbria antiserum was derived from immunizing rabbits with pu-
rified type 1 fimbriae as previously described (29). To remove nonspecific anti-
bodies, the antiserum was adsorbed with a fim gene cluster deletion mutant of E.
coli K1 RS218. The anti-O18 and anti-OmpA monoclonal antibodies were pre-
viously described (11, 25).
Construction of fimH deletion mutant. The fimH deletion mutant of RS218
was constructed by deleting the fimH gene and replacing it with a chloramphen-
icol resistance cassette using the protocol described by Datsenko and Wanner
(5). Briefly, the wild-type strain was transformed with plasmid pKD46 (5), which
encodes the arabinose-inducible lambda red recombinase that promotes gene
recombination between linear DNA and the host chromosome based on ex-
tremely short stretches of homology (30 to 50 nucleotides). PCR primers mut-
fimH-F2 and mut-fimH-R2 (Table 1) contain 50 nucleotides of 5-flanking por-
tions exactly homologous to the 5 and 3 ends of the fimH gene, respectively.
The 3 ends of the primers are able to probe the plasmid, pKD3 (5), and amplify
the chloramphenicol resistance cassette from it. The resultant PCR product of
about 1 kb was gel purified. By electroporation, the purified PCR product was
then transferred into the pKD46-containing RS218, which had been incubated
with 10 mM of arabinose during the procedure of making competent cells. After
cultivation in Super Optimal Catabolite medium (Invitrogen, Carlsbad, CA) for
1 h at 37°C, the bacteria were plated onto Luria-Bertani (LB) agar containing
chloramphenicol (25 g/ml) and 10 mM arabinose to select for antibiotic-resis-
tant transformants and to cure pKD46. The resultant transformants were tested
with primers flank-fimH-F and flank-fimH-R to ensure that the wild-type gene
(fimH) had been entirely deleted and replaced with the chloramphenicol resis-
tance cassette.
fimH cloning and complementation of the fimH mutation. The primers CM27
and CM28 (Table 1), which contain ApaLI and SphI at their 5 ends, respec-
tively, were designed to amplify fimH from E. coli K1 RS218. The PCR product
was cut with ApaLI and SphI and ligated to the pACYC184-derived plasmid
pBG2-24 (30), which was cut with the same enzymes. The resultant plasmid was
designated pCHT5. For complementation, pCHT5 was transferred into the fimH
deletion mutant. pACYC184 was transferred into the wild-type strain and the
fimH deletion mutant as vector control.
Construction of the locked-off and locked-on mutants. The primers Ch2-F-
SacI and Ch2-R-BglII (Table 1) were used to amplify the upstream region of the
invertible element. The PCR product was flanked with SacI and BglII sites on its
5 end and 3 end, respectively. The primers Lock-off-BglII and Locked-R-XbaI
(Table 1) were used to amplify the invertible element oriented in phase-off
position and the downstream sequence. The resulting product was flanked with
BglII and XbaI site on its 5 end and 3 end, respectively. The two PCR products
were sequentially cloned into a commercial cloning vector, pCR-Blunt II-TOPO
(Invitrogen, Carlsbad, CA), and fused together with their BglII sites. The fused
fragment, fragment OFF, contains the same sequence as the phase-off-oriented
invertible element and its upstream and downstream regions with the exception
that the 9-bp IRL sequence was changed from 5-TTGGGGCCA-3 to 5-TTA
GATCTC-3. Fragment OFF was then cloned into the suicide vector pCVD442
by utilizing SacI and XbaI sites. The resulting plasmid, designated pCHT2, was
then subjected to the allelic-exchange procedure as previously described (2, 6).
The locked-off mutant was selected by DNA sequencing.
The primer pairs Ch3-F-XbaI and Ch3-R (Table 1) were used to amplify the
upstream region (designated fragment A) of the invertible element oriented in
phase-on position except that the 9-bp IRL sequence was changed from 5-TT
GGGGCCA-3 to 5-TTAGATCTC-3 and an XbaI site was added to the 5 end
of this PCR product. The primer pairs Locked-on-2 and Locked-R-XbaI (Table
1) were utilized to amplify the DNA fragment (designated fragment B) including
the whole invertible element oriented in phase-on position and the downstream
sequence. Like fragment A, the IRL sequence was changed in fragment B. An
XbaI site was added to its 3 end.
Since fragments A and B have 12 bp of overlap, the two fragments were mixed
as templates and subjected to PCR by using Ch3-F-XbaI and Locked-R-XbaI.
The resulting PCR product, fragment ON, was flanked with XbaI sites. XbaI-
digested fragment ON was cloned into NheI-digested pST76-C, which is a tem-
perature-sensitive suicide vector containing a chloramphenicol resistance gene
and a rare restriction site, I-SceI (23). The new plasmid was designated pCHT3.
pCHT3 was subsequently used in an allelic-exchange procedure as previously
described (22). Briefly, RS218 was transformed with pCHT3 and grown on LB
plates containing chloramphenicol (25 g/ml) at 30°C overnight. Several colonies
were selected and grown on chloramphenicol-containing LB plates at 42°C for
7 h and then transferred to 37°C for an additional 12 h of incubation. The
surviving bacteria contained the suicide vector integrated into the chromosome.
To remove the integrated plasmid and make the locked-on mutant, another
temperature-sensitive plasmid, pST76-ASceP, was transferred into the bacteria
and incubated at 30°C overnight. pST76-ASceP harbors an ampicillin resistance
gene and expresses I-SceI nuclease (22). The nuclease cut the I-SceI site in
integrated pCHT3, which killed the partial merodiploid strain, so that only the
bacteria that experienced the intramolecular recombination could survive. The
surviving bacteria were either the wild-type strain or the locked-on mutant. By
DNA sequencing, we selected the locked-on mutant. The selected bacteria were
then incubated at 37°C overnight to remove pST76-AScep.
Western blot analysis. OmpA and FimH expression in the wild-type E. coli and
mutant strains was examined as follows. Whole-bacterial-cell lysates were pre-
pared from overnight cultures. Equal amounts of whole-cell lysates were sepa-
rated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and
transferred to nitrocellulose membranes. Anti-OmpA monoclonal antibody and
anti-FimH serum were used as primary antibodies at a dilution of 1:2,000 to
detect OmpA and FimH, respectively. Goat horseradish peroxidase-conjugated
anti-mouse immunoglobulin G (IgG) antibodies and goat horseradish peroxi-
dase-conjugated anti-rabbit IgG antibodies were utilized as secondary antibodies
at a dilution of 1:3,000 to label the anti-OmpA and anti-FimH antibodies,
respectively. The signals were visualized with the Amersham ECL Western
detection system (Amersham, Piscataway, NJ).
TABLE 1. Primers used
Primer Sequence
CM27..............................GGGGGTGCACTCAGGGAACCATTCAGGCA
CM28..............................GGGGCATGCTTATTGATAAACAAAAGT
mut-fimH-F2..................TACCTACAGCTGAACCCAAAGAGATGATTGTAATGAAACGAGTTATTACCCATATGAATATCCTCCTTAGT
mut-fimH-R2 .................TTGCGTACCAGCATTAGCAATGCCCTGTGATTTCTTTATTGATAAACAAAGTGTAGGCTGGAGCTGCTTC
flank-fimH-F..................GAGCCACTCAGGGAACCATT
flank-fimH-R .................TTTAGCTTCAGGTAATATTGCGTACCA
Ch1-F..............................AGTAATGCTGCTCGTTTTGC
Ch1-R.............................GACAGAGCCGACAGAACAAC
Ch2-F-SacI.....................TCGAGCTCAATTCGCCTGTTTCCATAC
Ch2-R-BglII...................GGGAGATCTAATTGTCTTGTATTTATTTG
Lock-off-BglII ................GGGGAGATCTCAACTGTCTATATCATAAATAAG
Locked-R-XbaI .............GCGTCTAGATCCTGTTATCACATTATCTG
Ch3-F-XbaI....................GCTCTAGAAATTCGCCTGTTTCCATAC
Ch3-R.............................TGAGTCAAAAGAGATCTAATTGTCTTGTATTTATTTG
Locked-on-2...................TACAAGACAATTAGATCTCTTTTGACTCATAGAGGAAAG
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E. coli invasion and association assays in HBMEC. Invasion assays were
performed using gentamicin protection assay as previously described (25) with a
minor adjustment. Briefly, confluent monolayers of HBMEC grown in 24-well
plates were infected with 107 bacteria at a multiplicity of infection of 100. After
90 min of incubation at 37°C, the monolayers were washed with phosphate-
buffered saline (PBS), incubated with gentamicin-containing medium (100 g/
ml) for 1 h to kill extracellular bacteria, and then washed three times with PBS.
HBMEC were lysed by incubation in sterile water at room temperature for 30
min. The released intracellular bacteria were enumerated by plating on sheep
blood agar. The actual invasion rates were calculated by dividing the number of
bacteria invading by the amounts of the original inoculum. Results were pre-
sented as relative invasiveness, percent invasion compared with the wild-type
RS218, which was arbitrarily set at 100%. Association assays were performed like
the invasion assay except that the gentamicin treatment step was omitted.
Invertible element orientation assay. The invertible element orientation assay
utilized the asymmetrical digestion site of SnaBI within the invertible element. A
pair of primers, Ch1-F and Ch1-R (Table 1), were designed and able to amplify
a 602-bp fragment containing the invertible element from both the phase-on and
phase-off bacteria. When the invertible element is in the “on” position, SnaBI
digestion will produce fragments of 404 and 198 bp. Otherwise, the restriction
enzyme digestion will make fragments of 442 and 160 bp. The SnaBI-digested
PCR products were separated on a 1.5% agarose gel. To quantify the percentage
of phase-on bacteria, a standard curve was prepared as described previously (17)
except that we used defined numbers of locked-on and locked-off bacteria as
PCR templates. The intensities of each band of the DNA fragments were de-
termined using the ImageJ program download from the website of the National
Institutes of Health (http://rsb.info.nih.gov).
Immunofluorescence labeling of bacteria. Surface presentation of type 1 fim-
briae on free bacteria was assessed by immunofluorescent microscopy with an
anti-type 1 fimbria rabbit polyclonal serum as previously described (21) with a
minor adjustment. Briefly, overnight bacterial cultures were harvested and
washed with PBS once. Bacterial cells were fixed by mixing 200 l of bacteria
with 800 l of a 4% (wt/vol) solution of paraformaldehyde in PBS. The mixture
was incubated on ice for 20 min. The fixed bacteria were then washed twice with
PBS. Fifteen microliters of each sample was placed on a poly-L-lysine-coated
slide and air dried. Twenty-five microliters of a 1:10 dilution of anti-type 1
fimbria serum in PBS was placed on top of each sample, and the samples were
incubated for 1 h at room temperature in a moist chamber. After washing three
times with PBS, each slide was incubated with 25 l of goat fluorescein isothio-
cyanate-conjugated anti-rabbit IgG antibodies at a dilution of 1:100 in PBS for
1 h at room temperature in a moist chamber.
Surface presentation of type 1 fimbriae on HBMEC-bound bacteria was ex-
amined as follows. HBMEC grown on collagen-coated glass coverslips in 24-well
plates until confluence were subjected to E. coli association assay as described
above except that the HBMEC were not lysed. The samples on the coverslips
were fixed in 4% paraformaldehyde on ice for 20 min and washed with PBS
twice. The fixed samples were subjected to double immunofluorescence labeling
for HBMEC-bound bacteria and type 1 fimbriae on their surface. To label the
HBMEC-bound bacteria, anti-O18 monoclonal antibody (primary antibodies)
and goat rhodamine-conjugated anti-mouse IgG antibodies (secondary antibod-
ies) were utilized at a dilution of 1:50 and 1:100, respectively. The expression of
type 1 fimbriae was determined as described above.
Yeast aggregation assay. Yeast aggregation titers of E. coli strains were mea-
sured as described previously (30). Briefly, E. coli cultures, at an optical density
of 0.4 at 530 nm, were subjected to serial twofold dilutions in PBS and mixed with
commercial baker’s yeast cells (5 mg/ml). Aggregation was monitored visually,
and the titer was recorded as the highest dilution giving a positive aggregation
result.
Bacterial RNA extraction from HBMEC-associated and nonassociated E. coli
K1. HBMEC-associated and nonassociated E. coli was recovered from E. coli K1
incubated with HBMEC based on a differential lysis technique recently devel-
oped in our laboratory (F. Di Cello et al., submitted for publication). Briefly,
confluent HBMEC were incubated with E. coli RS218 at a multiplicity of infec-
tion of 100 for 90 min at 37°C. Following incubation, the bacteria in supernatant
were collected by centrifugation and designated as non-HBMEC associated. The
HBMEC monolayer was subsequently washed twice and lysed with RLT buffer
(Qiagen, Valencia, CA), and the HBMEC-associated E. coli RS218 was pelleted
by centrifugation.
Bacterial RNA was extracted with the Ribopure Bacteria kit (Ambion, Austin,
TX) according to the manufacturer’s instructions. The extracted RNA mixture
was purified with two silica column-based cleanup procedures to reduce protein
and genomic DNA contaminations. Crude bacterial RNA was first purified with
a silica filter cartridge (Ribopure Bacteria kit; Ambion), and then further cleaned
up with an RNeasy minicolumn combined with on-column DNase treatments as
instructed (RNeasy Mini kit; Qiagen). Finally, the purified RNA was eluted with
30 l nuclease-free water.
Fluorescent labeling and DNA microarray hybridization. Cy3- and Cy5-la-
beled cDNA probes were generated with an indirect labeling procedure. Briefly,
5 g purified bacterial total RNA was converted to aminoallyl-labeled cDNA
(aa-cDNA) by Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA)
combined with amine-modified random hexamer and aminoallyl-dUTP/de-
oxynucleoside triphosphates (ratio of dTTP:aminoallyl-dUTP was 1:4). After
selective degradation of template RNA molecules and single-strand aa-cDNA
purification with QIAquick MinElute PCR purification kit (Qiagen, Valencia,
CA), fluorescent dyes (CyDye Post-Labeling reactive dye pack; Amersham Bio-
sciences, Piscataway, NJ) were chemically coupled to the amine group on aa-
cDNA. Fluorescent dye-coupled cDNA was then purified with the QIAquick
PCR purification kit (Qiagen).
The purified Cy3- and Cy5-coupled cDNAs were combined and concentrated
by centrifugation in a spin filter (Nanosep; molecular weight cutoff, 30,000; Pall,
Ann Arbor, MI). The concentrated cDNA was resuspended in 50 l hybridiza-
tion buffer (Pronto! universal hybridization kit; Corning, NY). The hybridization
mixture was then denatured at 95°C for 5 min. After brief centrifugation, the
mixture was applied onto the arrayed area under a LifterSlip coverslip (Erie
Scientific, Portsmouth, NH). The assembled slide was placed in a hybridization
chamber (Corning) and incubated at 42°C for 16 to 18 h. Following hybridization,
slides were extensively washed for 1 min in 2 SSC (1 SSC is 0.15 M NaCl plus
0.015 M sodium citrate), 0.1% SDS at 42°C; 5 min in 2 SSC, 0.1% SDS at 42°C;
10 min in 1 SSC at room temperature; and 2 min in 0.1 SSC at room
temperature twice.
Data acquisition and analysis. Hybridized microarray slides were scanned at
10-m resolution (GenePix 4000B; Axon Instruments, Foster City, CA). DNA
microarray images were analyzed with GenePix 4.0 software (Axon). The signal
intensities between two channels were normalized with print-pin group loess
normalization. The differential expression of genes was also determined with the
Limma package from Bioconductor (http://www.bioconductor.org). The cutoff
adjusted P value of significance for differential expression was set as 0.01.
RESULTS
Microarray analysis of gene expression profile within the
fim cluster. We initially examined using DNA microarray anal-
yses whether the expression levels of fim cluster genes differ
between the HBMEC-associated bacteria and the unbound
bacteria during the host-bacterium interaction. After 90 min of
incubation of E. coli K1 RS218 with HBMEC, the HBMEC-
associated and unbound bacteria were collected and subjected
to mRNA extraction and E. coli DNA microarray analysis. The
associated bacteria showed higher expression levels of the fim
cluster genes, which encode type 1 fimbria components, than
the free bacteria (Fig. 1). The differences were significant for
the first three genes (fimA, fimI, and fimC) downstream of the
fim promoter. The expression levels of fimA, fimI, and fimC of
the HBMEC-bound bacteria are 216%  6%, 162%  11%,
and 204%  4%, respectively, compared with those of the free
bacteria (Fig. 1). Expression levels of the remaining down-
stream fim genes (fimD, fimF, fimG, and fimH) of the
HBMEC-bound bacteria ranged from 114% to 137% com-
pared with those of the free bacteria (Fig. 1). These results
suggest that type 1 fimbria may play a role in the interaction of
E. coli K1 with HBMEC.
The fimH deletion mutant of E. coli K1 is defective in bind-
ing to and invasion of HBMEC in vitro. To determine whether
type 1 fimbriae play a role in the E. coli binding to and invasion
of HBMEC, an isogenic fimH deletion mutant was generated
from strain RS218. The growth characteristics of the wild-type
RS218 and the RS218-fimH isogenic mutant were similar on
BHI and blood agar. Western blot analysis of the parent and
the mutant strains with anti-FimH antibodies confirmed that
VOL. 73, 2005 TYPE 1 FIMBRIATED E. COLI K1 AND HBMEC 2925
only the parent strain and not the mutant expressed the FimH
protein (see Fig. 3B). Immunofluorescence microscopy with an
anti-type 1 fimbria serum showed that a very low (1%) per-
centage of the fimH deletion mutant cells were type 1 fimbria
piliated.
The RS218-fimH isogenic mutant was then investigated for
its ability to bind and invade HBMEC. We observed that the
mutant exhibited significantly less binding to HBMEC com-
pared to the parent strain (33% 7% of the wild-type RS218).
The mutant also showed only 7%  1% of invasion frequency
of the wild-type RS218 (Fig. 2A). In addition, to confirm that
the above results were not caused by a polar effect of the fimH
gene deletion, complementation experiments were performed.
The RS218 fimH was amplified with PCR and subcloned into
the pACYC184-derived plasmid pGB2-24 (30). The mutant
was transformed in trans with the fimH-carrying plasmid or
with the vector pACYC184. The wild-type strain was also
transformed with pACYC184 as a control. The above trans-
formants were then subjected to HBMEC association and in-
vasion assays. Both the association and invasion frequencies of
the mutant harboring the fimH-containing plasmid were re-
stored to the levels of the wild type, whereas the association
and invasion frequencies of the mutant harboring pACYC184
were significantly lower than those of the parent strain (Fig.
2B). The results indicate that type 1 fimbria is an important
determinant for E. coli K1 RS218 to adhere and invade
HBMEC.
Construction and characterization of the type 1 fimbria
locked-on and locked-off mutants of RS218. As mentioned in
the introduction, type 1 fimbrial expression is phase variable
(1), so the wild-type RS218 population is likely to be a heter-
ogeneous mixture of two subpopulations: the phase-on sub-
group, which expresses type 1 fimbriae, and the phase-off sub-
group, which does not produce this fimbria. Therefore, the
frequencies of the wild-type RS218 adherence to and invasion
of HBMEC are likely to stem from a mixture of type 1 fimbri-
ated and nonfimbriated bacteria. In order to examine the con-
tributions of phase-on and phase-off subpopulations to inter-
action with HBMEC, we constructed isogenic mutants of
RS218 whose fim promoter-containing invertible elements
were fixed in either “on” or “off” orientation by changing the
wild-type IRL sequence from 5-TTGGGGCCA-3 to 5-TTA
GATCTC-3(see Materials and Methods). The fim promoter
of the locked-on mutant is constitutively in the “on” orienta-
tion to allow transcription of fim genes, while that of the
locked-off mutant is in “off” orientation and is not able to
produce type 1 fimbriae. The two mutants were used to simu-
late the phase-on and phase-off subgroups of the wild-type
strain (see the following section). Their genotypes were con-
firmed by the invertible element orientation assay as described
in Materials and Methods. After 16 h of cultivation in BHI, the
locked-on mutant and the locked-off mutant still showed their
expected restriction patterns, confirming the genotypes of the
phase-locked mutants and the stability of their genotypes,
while the wild-type strain showed the mixed pattern of the two
mutants, indicating coexistence of type 1 fimbrial phase-on and
phase-off bacteria in the wild-type RS218 population (Fig. 3A).
To determine the protein expression level of type 1 fimbriae
in these mutants, Western blot analysis of the two phase-
locked mutants, the wild-type RS218, and the RS218-fimH
isogenic mutant with anti-FimH antibody was performed,
FIG. 1. The expression levels of the fim genes in HBMEC-bound
bacteria compared to those in free bacteria after 90 min incubation of
E. coli K1 strain RS218 with HBMEC. The expression levels in the
HBMEC-bound bacteria are presented as the percentage in compar-
ison to those in the free bacteria (which was set at 100% arbitrarily).
Data shown are the means  standard deviations derived from three
independent experiments. *, P  0.01 compared to free bacteria.
FIG. 2. The RS218-fimH isogenic mutant showed decreased association and invasion rates in comparison to the wild-type RS218 (A). The
defects of the mutant were restored by complementation with the fimH gene (B). pCHT5, which was derived from the vector plasmid pACYC184,
harbors fimH from E. coli K1 RS218. Hatched and filled bars indicate relative association and invasion rates, respectively, compared with the
wild-type strain RS218, which was set at 100%. The invasion frequencies of the wild-type RS218 (A) and the pACYC184-harboring wild-type
RS218 (B) were 0.81%  0.11% and 0.57%  0.09% of the original inocula, respectively, while their association frequencies were 18%  4%
(A) and 15%  3% (B) of the original inocula. Data shown are representative of three independent experiments done in triplicate. Results are
shown as means  standard deviations.
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which revealed that the RS218-fimH isogenic mutant and the
locked-off mutant were unable to express the type 1 fimbrial
adhesin FimH (Fig. 3B). In contrast, the wild-type RS218 and
the locked-on mutant showed similar levels of FimH expres-
sion (Fig. 3B).
To assess type 1 fimbria piliation among the phase-locked
mutants and the wild-type RS218, immunofluorescence mi-
croscopy was performed by labeling the bacteria with anti-type
1 fimbria serum. The wild-type RS218 and the locked-on mu-
tant showed 19%  5% and 97%  3% of the bacteria ex-
pressing the fimbriae on the cell surface, respectively (Table 2).
No fimbria was detected on the surface of the locked-off mu-
tant.
Type 1 fimbriated bacteria are capable of aggregating yeast
cells through their ability to bind mannosylated glycoproteins
present on the surface of yeast cells. The yeast aggregation
assays illustrate the level of type 1 fimbria piliation (27), and
mannose is shown to abolish the aggregation. We compared
the yeast aggregation titers among the wild-type strain and the
mutants which were grown overnight in BHI. The locked-on
mutant showed twofold-higher aggregation compared to the
wild-type strain, while the locked-off mutant was incapable of
any yeast aggregation (Table 2). The yeast aggregations by the
wild-type and locked-on mutant strains were abolished by ad-
dition of 50 mM of mannose (methyl -D-mannopyranoside),
confirming that the aggregations are due to type 1 fimbria
piliation. These results are correlated with the percentages of
type 1 fimbria piliated cells in the populations of these strains.
OmpA protein is the E. coli K1 determinant that was shown
to be important for bacterial binding to and/or invasion of
BMEC (8, 10). To investigate whether the type 1 fimbria ex-
pression affects the expression of OmpA, Western blot analysis
of the whole-cell lysates of the phase-locked mutants, the
RS218-fimH isogenic mutant, and the wild-type strain with
anti-OmpA antibodies was performed. The OmpA expression
levels among these strains showed no significant difference
(Fig. 3C).
The phenotype of the type 1 fimbria locked-on and locked-off
mutants in binding to and invasion of HBMEC. The phase-
locked mutants were examined for their association and inva-
sion rates compared with the wild-type RS218. The locked-on
mutant exhibited 273%  53% and 253%  43% of associa-
tion and invasion frequencies of the wild-type strain, respec-
tively (Fig. 4). Similar to the RS218-fimH isogenic mutant,
the locked-off mutant exhibited 37%  7% of association fre-
quency of the wild-type strain and showed only 10%  2% of
invasion frequency of the wild type (Fig. 4). These findings
FIG. 3. Characterization of the locked-on and locked-off mutants
compared to the wild-type RS218 and RS218-fimH isogenic mutant.
The genotypes of the mutants were confirmed with the invertible
element orientation assay. Lane a, the locked-on mutant; lane b, the
locked-off mutant; lane c, the wild-type RS218 (A). After overnight
cultivation in BHI, no FimH was expressed in the locked-off and the
RS218-fimH isogenic mutants, while the locked-on mutant and the
wild-type strain showed similar levels of FimH expression (B). OmpA
expression was similar among the mutants and the wild-type RS218
(C). Lane 1, the wild-type RS218; lane 2, the locked-on mutant; lane 3,
the locked-off mutant; lane 4, the RS218-fimH isogenic mutant.
FIG. 4. The locked-on mutant exhibited significantly higher asso-
ciation and invasion rates than the wild-type RS218, while the locked-
off mutant showed significantly lower invasion and association rates
than the wild-type RS218. Hatched and filled bars indicate relative
association and invasion rates, respectively, compared with the wild-
type strain, which was set at 100%. The invasion and association
frequencies of the wild-type RS218 were 0.7%  0.09% and 19% 
3% of the original inocula, respectively. Data shown are representative
of three independent experiments done in triplicate. Results are shown
as means  standard deviations of the triplicate. WT, wild type.
TABLE 2. Yeast aggregation by RS218 and phase-locked mutants
Straina
% of
type 1
fimbria
piliationb
Yeast aggregation
titer without
addition of mannose
Yeast
aggregation titer
with addition of
50 mM mannose
Wild-type RS218 19  5 16c —
Locked-on mutant 97  3 32 —
Locked-off mutant 0  0 —d —
a The strains were grown in BHI broth overnight with shaking at 200 rpm.
b The results are shown as means  standard deviations of three independent
counts from different fields of the microscope. One hundred bacteria were
investigated for each count.
c Agglutination titers were recorded as the highest twofold dilution giving a
positive aggregation, starting from an optical density at 530 nm of 0.4.
d —, no aggregation was observed.
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suggest that rates of HBMEC association and invasion are
directly correlated with proportion of type 1 fimbriated bacte-
ria in the bacterial inocula. We next examined whether in-
creased and decreased invasion frequencies observed with the
locked-on and locked-off mutants are secondary to their effects
on HBMEC association by estimating invasion index (relative
invasion rate/relative association rate). The values of invasion
index for the locked-on, locked-off, and RS218-fimH isogenic
mutants were 0.93, 0.27, and 0.21, respectively (the ratio of the
wild-type RS218 is arbitrarily set at 1). The index of the
locked-on mutant is close to that of the wild type, suggesting
that in comparison with the wild-type strain the increased
invasion rate is likely due to the increased binding ability of this
mutant. In contrast, the locked-off mutant and the RS218-
fimH isogenic mutant showed significantly lower values, sug-
gesting that the decreased invasion rates of both mutants may
be due to decreased binding ability as well as their defects in
invasion ability.
Mannose treatment decreases association of the locked-on
mutant but not the locked-off mutant with HBMEC. To exam-
ine whether the different invasion and association frequencies
of the phase-locked mutants are related to type 1 fimbria
piliation, we performed association assays of the two mutants
under different concentrations of mannose. Mannose (methyl
-D-mannopyranoside) exhibited a dose-dependent decrease
in the association rates of the locked-on mutant with HBMEC
(Fig. 5A). In contrast, different concentrations of mannose did
not significantly affect association rates of the locked-off mu-
tant (Fig. 5B). In addition, with the addition of 10 mM of
methyl -D-mannopyranoside, the association level of the
locked-on mutant became very close to that of the locked-off
mutant (8.1%  1.1% of the original inoculum versus 7.5% 
0.8% of the original inoculum, respectively). These results
indicate that different association rates of the two mutants are
mainly due to different levels of type 1 fimbria piliation.
Type1 fimbria phase-on bacteria are predominant in E. coli
K1 RS218 cells associated with HBMEC. The above findings
indicate that type 1 fimbriae are important for E. coli K1 to
interact with HBMEC and that the type 1 fimbria locked-on
mutant is more capable of binding and invading HBMEC than
the locked-off mutant. We, therefore, speculated that the type
1 fimbrial phase-on bacteria are the major subgroup in the
wild-type E. coli K1 that interact with HBMEC and performed
the invertible element orientation assays to determine the per-
centage of cells whose fim promoters were in the “on” orien-
tation in the wild-type E. coli K1 strain RS218 associated with
HBMEC. RS218 was incubated with HBMEC for 90 min as
described for the HBMEC association assays. The cell-associ-
ated bacteria and the free bacteria in the supernatant were
collected and subjected to the invertible element orientation
assay, as well as the total bacteria recovered after 90 min
incubation with HBMEC. About 86% of HBMEC-associated
bacteria had fim promoters which were found to be in the “on”
orientation. The supernatant free bacteria and the total bac-
teria, which were collected after 90 min of incubation with
HBMEC, showed only about 15% and 17%, respectively, of
bacteria having fim promoters that were in the “on” orienta-
tion. In addition, type 1 fimbria piliation rates of the HBMEC-
bound bacteria and unbound bacteria were assessed by using
immunofluorescence microscopy with an anti-type 1 fimbria
serum. Of the HBMEC bound-bacteria 91%  6% were pili-
ated, while of the unbound bacteria only 11%  4% were
piliated (Fig. 6). These findings indicate that the type 1 fim-
briated bacteria are the major subgroup of E. coli K1 RS218
interacting with HBMEC.
DISCUSSION
E. coli K1 is the most common gram-negative bacterium that
causes meningitis during the neonatal period. To cause men-
ingitis, the pathogen needs to cross the blood-brain barrier. We
have utilized the in vitro blood-brain barrier model comprised
of HBMEC to study how the meningitis-causing pathogen
traverses the blood-brain barrier. E. coli adhesion to HBMEC
is considered an important first step for circulating E. coli to
withstand the blood flow and cross the blood-brain barrier in
vivo, but the microbial determinants contributing to E. coli
adhesion to HBMEC are unclear. In the present study, we
demonstrated for the first time that type 1 fimbriae contribute
to the interaction between the meningitis-causing E. coli K1
and HBMEC and that the type 1 fimbria phase-on population
is the predominant group interacting with HBMEC.
The RS218-fimH isogenic mutant showed significantly
lower adhesion and invasion rates in HBMEC compared with
the wild-type RS218, and the mutant phenotypes were trans-
complemented with a fimH-harboring plasmid. FimH is the
FIG. 5. Mannose (methyl -D-mannopyranoside) dose dependently decreased association with HBMEC of the locked-on mutant (A) but did
not affect the association of the locked-off mutant (B). The association rates are presented as percentages of the rates obtained with 0.1 mM of
methyl -D-mannopyranoside, which was set at 100% arbitrarily. The association frequencies of the locked-on and locked-off mutants in 0.1 mM
of methyl -D-mannopyranoside were 28%  2% and 8%  1% of their original inocula, respectively. Results shown are representative of three
independent experiments done in triplicate. Results are shown as means  standard deviations.
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adhesin of type 1 fimbriae and has also been shown to be
involved in the biosynthesis of type 1 fimbria (14, 15). This
concept is consistent with our demonstration that very few type
1 fimbria piliated cells were found in the fimH deletion mutant
population. These findings indicate that type 1 fimbriae play an
important role in E. coli K1 strain RS218 adhesion to and
invasion of HBMEC.
Type 1 fimbria expression is known to be phase variable, and
the wild-type strain population is a heterogeneous mixture of
type 1 fimbriated and nonfimbriated bacteria. The association
and invasion frequencies of the wild-type E. coli K1 RS218 are,
therefore, likely to be the net effect of the two populations.
Bacteria alternate between these two states by switching the
fim promoter between “on” orientation, which allows tran-
scription of fim genes, and “off” orientation, which prevents
expression of fim genes. It is impossible to keep the wild-type
bacteria in either the fimbriated or nonfimbriated state during
the host-bacterium interaction. To further assess the role of
type 1 fimbriae in the interactions of RS218 with HBMEC, we
constructed the type 1 fimbria phase-locked mutants to simu-
late the type 1 fimbria phase-on and phase-off bacteria of the
wild-type strain. The phase-locked isogenic mutants were con-
structed by changing five out of nine nucleotides of the IRL
sequence without interruption or deletion of genes, and their
genotypes were confirmed with DNA sequencing and the in-
vertible element PCR assay. After overnight cultivation the
phase-locked mutants still showed the same genotypes, con-
firming the stability of these mutants. Western blot analysis of
the phase-locked mutants to determine FimH expression level
showed no FimH expression in the locked-off mutant. No type
1 fimbria piliation was detected on the locked-off mutant, and
the mutant is incapable of yeast aggregation. The locked-off
mutant, as expected, doesn’t express FimH and type 1 fimbriae,
since the fim promoter is not in the right orientation to allow
transcription of fim genes. In contrast, the locked-on mutant
consisted of about 97% type 1 fimbria piliation and exhibited
twofold-higher yeast aggregation titer than the wild-type strain,
which showed about 19% type 1 fimbria piliation. Western blot
analysis with anti-FimH antiserum, however, revealed similar
levels of FimH between the locked-on mutant and the wild-
type strain. There are two possible explanations for different
yeast aggregation and Western blot results between the
locked-on mutant and the wild-type RS218. First, Western blot
analysis may not be sensitive enough to differentiate the FimH
protein levels between the wild-type RS218 and the locked-on
mutant. Second, since FimH is only one of the minor compo-
nents of type 1 fimbria structure (a copy of type 1 fimbria
consists about 1,000 copies of the major subunit protein, FimA,
while only a small amount of the adhesin, FimH, is needed for
a fimbria [28]), FimH production in E. coli may not correctly
reflect type 1 fimbria piliation on the cell surface. This second
possibility is supported by our microarray results, which
showed that the transcription level of the type 1 fimbrial major
subunit gene, fimA, in HBMEC-bound bacteria was about two-
fold higher than that in the free/unbound bacteria, while the
fimH transcription level in HBMEC-bound bacteria is only
about 1.3-fold higher than that in free bacteria. Thus, the
expression level of FimA may be more representative of type 1
fimbria production in E. coli.
The locked-on mutant showed about 2.7- and 2.5-fold-
higher association and invasion rates in HBMEC than the
wild-type strain, while the locked-off mutant exhibited about
36% of the association and 7% of the invasion abilities of the
wild-type strain in HBMEC. The difference in HBMEC asso-
ciation and invasion rates of the locked-on, the locked-off, and
the wild-type strains may be related to the proportion of type
FIG. 6. Type 1 fimbria piliation of E. coli K1 RS218 interacting
with HBMEC. (A) To assess type 1 fimbria piliation of unbound
bacteria, the unbound bacteria were detected with light microscopy
(left panel) and their type 1 fimbria piliation was detected with immu-
nofluorescence microscopy with a rabbit antiserum directed against
type 1 fimbria and fluorescein isothiocyanate-conjugated anti-rabbit
IgG antibodies (right panel). (B) To asses type 1 fimbria piliation of
HBMEC-bound bacteria, double immunofluorescence microscopy was
performed. The HBMEC-bound bacteria were detected with anti-O18
antibody and rhodamine-conjugated anti-mouse IgG antibodies (left
panel), and their type 1 fimbria piliation was detected as described in
panel A (right panel). (C) The percentages of type 1 fimbria piliated
bacteria in the unbound and HBMEC-bound bacteria population were
determined. Data shown are the means  standard deviations of three
independent determinations from different fields of the microscope.
One hundred bacteria were examined for each determination.
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1 fimbriated bacteria present in the bacterial population at the
time of association and invasion assays. Type 1 fimbriae spe-
cifically bind mannose, and addition of methyl -D-mannopy-
ranoside decreased the adherence to HBMEC of the
locked-on mutant, not the locked-off mutant, suggesting that
the difference in the adherence to HBMEC between the phase-
locked mutants is mainly due to type 1 fimbrial expression.
However, we cannot completely exclude the possibility that
some other genes involved in E. coli K1 adherence to HBMEC
may be affected in the phase-locked mutants. OmpA is shown
to be an important determinant of E. coli K1 to bind and
invade brain microvascular endothelial cells (8, 10). Our data
indicated that the expression levels of OmpA protein did not
differ among the wild-type RS218 and the phase-locked mu-
tants. Thus, these different adherence rates of the locked-on
and locked-off mutants for HBMEC are not related to differ-
ent levels of OmpA expression.
The locked-on mutant was shown to have significantly
greater invasion into HBMEC compared to the wild-type bac-
teria, while the locked-off mutant’s invasion was significantly
less than that of the wild-type bacteria. The difference in their
invasion rates may stem from different binding and/or invasive
abilities. We, therefore, compared the invasion index, calcu-
lated from relative invasive rate/relative association rate. The
invasion index of the locked-on mutant was similar to that of
the wild-type RS218, suggesting that the adherent locked-on
mutant is as effective as the adherent wild-type strain in invad-
ing HBMEC and that the increased ability to invade HBMEC
is mainly due to increased binding ability of the locked-on
bacterial population.
In contrast, the locked-off mutant showed significantly lower
invasion index than the locked-on mutant and the wild-type
RS218. This finding suggests that the locked-off mutant has
decreased binding ability for HBMEC but may also have the
decreased invasion ability compared with the wild-type RS218
and the locked-on mutant. Type 1 fimbriae have been shown to
activate neutrophils and mast cells (18, 34). Type 1-fimbriated
E. coli is able to trigger phosphorylation of focal adhesion
kinase, activation of phosphoinositide 3-kinase, and complex
formation between focal adhesion kinase/phosphoinositide-3
kinase and vinculin/-actin when invading bladder epithelial
cells (19). These studies reveal that type 1 fimbriae are capable
of triggering intracellular signaling in mammalian target cells.
Type 1 fimbriae of E. coli K1 may also be able to stimulate
intracellular signal transduction in HBMEC, which helps E.
coli K1 internalize its host cell, and decreased invasion rate of
the locked-off mutant may stem from the failure of type 1
fimbria-mediated intracellular signaling. Studies are in
progress to determine whether type 1 fimbria-mediated intra-
cellular signaling is involved in E. coli K1 invasion of HBMEC.
Our demonstrations of decreased association and invasion
abilities of the RS218-fimH isogenic mutant and different
association and invasion rates with the phase-locked mutants
indicate that type 1 fimbriae play an important role in E. coli
K1-HBMEC interaction. Since expression of type 1 fimbriae is
phase variable in wild-type E. coli K1, we hypothesized that,
during the E. coli K1-host cell interaction, the type 1 fimbrial
phase-on population is the dominant subgroup interacting with
their target cells. To confirm this hypothesis, we used the
invertible element orientation assay to determine the real-time
percentage of cell population whose fim promoters were in the
“on” orientation in the wild-type bacteria interacting with
HBMEC. In comparison to only 17% of the population in the
total bacteria collected after 90 min incubation with HBMEC
and 15% of the population in the bacteria not associated with
HBMEC having their fim promoters “on,” the fim promoters
of 86% of the HBMEC-associated bacteria were found to be in
the “on” orientation. In addition, we demonstrated that about
91% of the HBMEC-bound bacteria expressed type 1 fimbria
on the cell surface, but only about 11% of the unbound bac-
teria were type 1 fimbria piliated. These findings support the
concept that the type 1 fimbria phase-on bacteria are the pre-
dominant subpopulation interacting with HBMEC.
In summary, our data demonstrated for the first time that
type 1 fimbriae play an important role in adherence to and
invasion of HBMEC, and the type 1 fimbria phase-on bacteria
represent the predominant population interacting with
HBMEC by E. coli K1 strain RS218. These findings imply that
type 1 fimbriae are important in the pathogenesis of E. coli K1
meningitis. Studies are in progress to further elucidate the
mechanism(s) involved in type 1 fimbria-mediated E. coli K1
binding to and invasion of HBMEC.
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